Predictive In Vitro Models Developing Better Models to Predict Clinical Outcomes 21 – 22 September 2011
Double Tree Suites Hilton, Boston, MA, USA

Media Partners


  • DSEC DSEC is a peer membership of over 2,000 drug safety leaders with the common objective of advancing the development of better and safer medicines. www.drugsafetycouncil.org Read more...

  • IIVS The Institute for In Vitro Sciences (IIVS) is a non-profit organization wholly dedicated to the advancement of alternative testing methods. www.iivs.org Read more...

  • In Vitro Toxicology Society The IVTS was founded under a constitution in 1988 for scientists active in the study, practice or development of in vitro toxicology. www.ivts.org.uk Read more...

  • PFQ In its 11th year, Pharmaceutical Formulation & Quality (PFQ) focuses on the unique niche of post-discovery development and validation, delivering a unique blend of content that no other pharmaceutical publication in the market offers. www.pharmaquality.com Read more...

  • TechNet TechnologyNetworks.com

  • PharmaVOICE PharmaVOICE magazine, reaching more than 25,000 BPA-qualified life-sciences executives, is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. www.pharmavoice.com Read more...

  • IPT IPT was launched in 1997 to provide the pharmaceutical industry with quality information on the latest cutting-edge technologies. www.iptonline.com Read more...

  • NC3RS The UK’s National Centre for the Replacement, Refinement and Reduction of Animals in Research is an independent scientific organisation, established following a review by the House of Lords, to support innovation in the UK bioscience sector by driving the development of new models and tools with reduced reliance on animals and improved animal welfare. www.nc3rs.org.uk Read more...

  • speaker

    Human Focused Testing Human Focused Testing bridges the information gap between those in search of human tissues or in vitro assays and those who can provide those tissues, assays and associated products and services. Read more...

  • The Pharma Letter www.thepharmaletter.com